This is what I was getting too.

We pretty much ALL have experience with this! I have dense breasts, and that has led to 3 stereotactic biopsies, one of which turned up a 11 mm tumor (12/6/2021). I also was called back in 2018 because of dense breasts, had a stereotactic biopsy, and it was declared benign. (I still think sticking a 3 foot long into my right breast may have stirred it up and set the scene for the 12/6/2021 experience. I also had to have one on Valentine's Day, 2023. I have 3D mammograms, but, in my own experience, my doctors never want to order anything that could be considered expensive, even if it is more accurate or better. My Illinois oncologist refused to order an oncotype, which means that I never found out that my oncotype score was 29 until 17 months had passed and I had moved to another oncologist in Texas who secured it for me long after the fact. I have asked about MRIs and I have not gotten very far. I have asked about the Signaterra test for staying on top of recurrence: same reaction. I have asked about the C-27 or C-29 markers (I may have the numbers wrong). Nobody wants to order any of these, citing a variety of factors, including that the tumor was not of a bad enough grade and the seminal lymph node biopsy did not show any spread. I'm getting the definite message that 3D mammograms is about as good as it is going to get for me. I did pay for an ultrasound (HerScan) out-of-pocket ($300) and that led to the plan for a third biopsy, which was averted by gathering up all of the routinely administered mammograms and examining them for any change in the calcification that exists in both breasts. It is disconcerting that the expense of a test (eg., an oncotype) makes it off limits for the patient because her doctor "doesn't want to get dinged by Medicare."